📰 Nasdaq Vxrt News
Nasdaq Vxrt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Vxrt. Real-time updates on events, politics, business and more.
February 27, 2024
Vaxart (NASDAQ:VXRT – Get Free Report) and Alvotech (NYSE:ALVO – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, dividends, profitability and institutional ownership. Risk and Volatility Vaxart has a beta of 0.43, meaning […]
January 16, 2024
SOUTH SAN FRANCISCO, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it has entered into a common stock...
November 30, 2023
Vaxart, Inc. (NASDAQ:VXRT – Get Free Report) shares crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.82 and traded as low as $0.70. Vaxart shares last traded at $0.74, with a volume of 512,229 shares changing hands. Analysts Set New […]
October 13, 2023
Vaxart, Inc. (NASDAQ:VXRT – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.84 and traded as low as $0.69. Vaxart shares last traded at $0.70, with a volume of 466,763 shares trading hands. Analysts Set New Price Targets Separately, […]
September 11, 2023
Cantor Fitzgerald reaffirmed their overweight rating on shares of Vaxart (NASDAQ:VXRT – Free Report) in a research report released on Thursday, Benzinga reports. The firm currently has a $4.00 target price on the biotechnology company’s stock. Vaxart Price Performance Shares of NASDAQ VXRT opened at $0.78 on Thursday. The stock has a market capitalization of […]
June 21, 2023
SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today encourages its stockholders of record on April 28, 2023,...
June 7, 2023
SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the pricing of its underwritten public...
May 11, 2023
Vaxart, Inc. (NASDAQ:VXRT – Get Rating)’s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.02 and traded as low as $0.85. Vaxart shares last traded at $0.86, with a volume of 512,683 shares traded. Vaxart Price Performance The firm has a market […]
March 30, 2023
Vaxart (NASDAQ:VXRT – Get Rating) and 4D Molecular Therapeutics (NASDAQ:FDMT – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings. Risk and Volatility Vaxart has a beta of 0.82, […]
December 1, 2022
Funding and support provided by Bill & Melinda Gates Foundation Study will focus on determining the ability of oral vaccine tablets to induce breast...